BiotechTube

apomine

Phase 1Completed
0 watching 0 views this week💤 Quiet
32
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Unspecified Adult Solid Tumor, Protocol Specific

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Trial Timeline

Aug 1, 1998 → —

NCT ID
NCT00003822

About apomine

apomine is a phase 1 stage product being developed by Sanofi for Unspecified Adult Solid Tumor, Protocol Specific. The current trial status is completed. This product is registered under clinical trial identifier NCT00003822. Target conditions include Unspecified Adult Solid Tumor, Protocol Specific.

Hype Score Breakdown

Clinical
10
Activity
5
Company
9
Novelty
3
Community
2

Clinical Trials (3)

NCT IDPhaseStatus
NCT00078026Phase 1/2Terminated
NCT00004049Phase 1Completed
NCT00003822Phase 1Completed

Competing Products

20 competing products in Unspecified Adult Solid Tumor, Protocol Specific

See all competitors
ProductCompanyStageHype Score
DJ-927 + capecitabineDaiichi SankyoPhase 1
33
E7389 + E7389 + E7389EisaiPhase 1
33
bevacizumab + enzastaurin hydrochlorideEli LillyPhase 1
33
SHR-1916Jiangsu Hengrui MedicinePhase 1
33
PembrolizumabMerckPhase 2
52
PI3K inhibitor BKM120 + docetaxelNovartisPhase 1
33
bevacizumab + cyclophosphamide + imatinibNovartisPhase 1
33
capecitabine/oxaliplatin/bevacizumab/RAD001 (XELOX-A-Ev)NovartisPhase 1
33
warfarinNovartisPhase 1
33
RLY-1971RochePhase 1
33
Domvanalimab + ZimberelimabGilead SciencesPhase 1
32
BEZ235 + MEK162PfizerPhase 1
32
Utomilumab + ISA101bPfizerPhase 2
51
IrinotecanPfizerPhase 1
32
Ixabepilone + SunitinibPfizerPhase 1
32
ixabepilone + lapatinib ditosylateBristol Myers SquibbPhase 1
32
carboplatin + irinotecan hydrochlorideBristol Myers SquibbPhase 1
32
intoplicineSanofiPhase 1
32
apomineSanofiPhase 1
32
SorafenibBayerPhase 2
49

Other Products from Sanofi

Adacel®Approved
84
LACTIC ACID(ND)Approved
84
DupilumabApproved
84
glatiramer acetateApproved
84
INSULIN GLULISINE + INSULIN GLARGINEApproved
84